Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Should states include the drug benefit in the set of services for which their capitated health plans are at risk (the "carve-in" model)? Or should they pay for those medications directly (the "carve-out" model)? This is a question that many Medicaid managed care programs are asking.

Some states moving to 'carve out' model for pharmacy services